brokerbase

About tradingpattern.net

The movement of a security's price over a specific time period.

dedicated to value creation and applying the scientific method in finance

Search


www.brokerbase.ch network - market statistics - weekly update

www.brokerbase.ch High dividend yield stocks

www.brokerbase.ch network

3M Activision Blizzard Adobe Systems Affimetrix Airlines Akamai Tech Alcoa Altera Amazon.com American Express American Tower Amgen Amylin Pharma Analyst Rating AngloGold Apollo Group Apple Applied Materials AT&T Autodesk Automatic Data Processing Baidu Bank of America Baxter Bed Bath & Beyond Blackrock Boeing Broadcom C.H. Robinson CA Caterpillar Celgene Cephalon Charts Check Point Software Chevron Cintas Corporation Cisco Systems Citigroup Citrix Coca Cola Cognizant Comcast Costco Wholesale Cree Dell DENTSPLY DIRECTV Discount, Variety Stores DISH Disney Dow 30 Downgrade Dr. Reddy's Laboratories Du Pont eBay Electronic Arts EMC Corporation Expedia Express Scripts Extreme Networks Exxon Mobil FANNIE MAE Fastenal First Solar Fiserv Flextronics FLIR Ford Foster Wheeler FREDDIE MAC Freeport-McMoRan Garmin Genentech General Electric Genzyme Gilead Sciences Golden Star Resources Goldman Sachs Google Hansen Natural Hardware Healthcare Hecla Mining Henry Schein Hewlett Packard Hologic Home Depot Human Genome Science IBM Illumina Industry Infosys Initial Recommendation Intel InterActive Corp Intuit Intuitive Surgical Johnson & Johnson Joy Global JP Morgan Juniper Networks KKR KLA-Tencor Kraft Foods Lam Research Level 3 Liberty Global Liberty Media Life Technologies Linear Technology Lockheed Martin Logitech Marvell Technology MasterCard Maxim Integrated McDonalds Merck Merril Lynch Microchip Technology Microsoft Millicom Morgan Stanley Nasdaq 100 NetApp NETFLIX Network Network Appliance Newmont Mining News Corporation NII Holdings Noble NVIDIA O'Reilly Automotive Occidental Petroleum Oracle PACCAR Patterson Paychex Petrohawk PETROLEO BRASILEIRO Pfizer Procter & Gamble Qualcomm Quanta Renhe Commercial Holdings Research in Motion Riverbed Technology Ross Stores Royal Gold Ryanair S&P 500 salesforce.com SanDisk Seagate Sears Holdings Semiconductor - Integrated Circuits Services Sigma-Aldrich Software Southwest Airlines Staples Starbucks Steel & Iron Steel Dynamics Stericycle Symantec Synaptics Technology Teva Texas Instruments Ticker Travelers Uncategorized United Continental Holdings United Technologies Upgrade Urban Outfitters VeriSign Verizon Vertex Pharmaceuticals Visa Wal Mart Warner Chilcott Wells Fargo Wynn Resorts Xilinx XTO Yahoo Zoltek

www.brokerbase.ch network - archived market statistics

Blogroll

Recent Posts

Pfizer

« Previous Entries

Pfizer buy – New Analyst Rating from UBS AG

Friday, May 11th, 2012

Pfizer buy – New Analyst Rating from UBS AG

Thursday, May 10th, 2012

Pfizer equal-weight – New Analyst Rating from Barclays Capital

Friday, May 4th, 2012

Pfizer equal-weight – New Analyst Rating from Barclays Capital

Thursday, May 3rd, 2012

Pfizer halten – New Analyst Rating from Independent Research GmbH

Thursday, May 3rd, 2012

Pfizer overweight – New Analyst Rating from JP Morgan Chase & Co.

Thursday, May 3rd, 2012

Pfizer buy – New Analyst Rating from UBS AG

Thursday, May 3rd, 2012

Pfizer halten – New Analyst Rating from Independent Research GmbH

Wednesday, May 2nd, 2012

Pfizer spuert Patentverlust beim Topseller Lipitor

Tuesday, May 1st, 2012

Pfizer buy – New Analyst Rating from Jefferies & Company Inc.

Tuesday, April 24th, 2012

Pfizer halten – New Analyst Rating from Independent Research GmbH

Monday, April 23rd, 2012

Nestle kauft Pfizers Babynahrung fuer 11,85 Mrd USD

Monday, April 23rd, 2012

WSJ – Nestle erhaelt Zuschlag fuer Pfizers Babynahrung – Kreise

Monday, April 23rd, 2012

Pfizer halten – New Analyst Rating from Independent Research GmbH

Friday, April 20th, 2012

Danone bietet fuer Pfizers Babynahrungsgeschaeft – Medien

Friday, April 20th, 2012

WSJ – Nestle vor der Uebernahme von Pfizers Babynahrung – Kreise

Wednesday, April 18th, 2012

Pfizer buy – New Analyst Rating from Goldman Sachs Group Inc.

Thursday, March 29th, 2012

Pfizer buy – New Analyst Rating from Goldman Sachs Group Inc.

Wednesday, March 28th, 2012

Pfizer outperform – New Analyst Rating from Sanford C. Bernstein and Co., Inc.

Tuesday, March 27th, 2012

Pfizer buy – New Analyst Rating from Jefferies & Company Inc.

Tuesday, March 20th, 2012

Bayer-Chef sieht wenig Chancen fuer Pfizer-Gebot – Zeitung

Friday, March 16th, 2012

Bayer bietet Milliarden fuer Pfizer-Tiermedizin – Presse

Friday, March 9th, 2012

WSJ – Novartis und Bayer an Pfizers Tiermedizinsparte interessiert

Thursday, March 8th, 2012

Pfizer buy – New Analyst Rating from UBS AG

Friday, February 24th, 2012

Pfizer buy – New Analyst Rating from UBS AG

Thursday, February 23rd, 2012

Pfizer kann Viagra 6 Monate laenger exklusiv vermarkten

Sunday, February 19th, 2012

Pfizer outperform – New Analyst Rating from Credit Suisse Group

Thursday, February 2nd, 2012

Pfizer spuert Patentverlust beim Topseller Lipitor

Tuesday, January 31st, 2012

Pfizer outperform – New Analyst Rating from Sanford C. Bernstein and Co., Inc.

Tuesday, January 31st, 2012

Pfizer overweight – New Analyst Rating from JP Morgan Chase & Co.

Tuesday, January 24th, 2012

Pfizer verkaufen – New Analyst Rating from Hamburger Sparkasse AG (Haspa)

Tuesday, January 10th, 2012

Pfizer buy – New Analyst Rating from Goldman Sachs Group Inc.

Tuesday, January 10th, 2012

Pfizer outperform – New Analyst Rating from Sanford C. Bernstein and Co., Inc.

Monday, January 9th, 2012

Pfizer buy – New Analyst Rating from UBS AG

Tuesday, December 13th, 2011

WSJ – Bayer-Mittel Nexavar droht Konkurrenz von Pfizer-Arznei

Wednesday, December 7th, 2011

Pfizer halten – New Analyst Rating from Independent Research GmbH

Friday, December 2nd, 2011

Fuer Pfizer beginnt mit Wegfall des Lipitor-Patents neue Zeit

Thursday, December 1st, 2011

Pfizer lizensiert Generikaversion der Blockbuster-Arznei Lipitor

Wednesday, November 30th, 2011

Pfizer outperform – New Analyst Rating from Sanford C. Bernstein and Co., Inc.

Wednesday, November 30th, 2011

Pfizer halten – New Analyst Rating from Raiffeisen Centrobank AG

Thursday, November 10th, 2011

Pfizer ( PFE ) Downgrade from Buy to Hold – Analyst rating from Standpoint Research

Tuesday, November 1st, 2011

Pfizer (PFE) Downgrade from Buy to Hold – Analyst rating from Standpoint Research

Tuesday, November 1st, 2011

Pfizer vervierfacht Gewinn und erhoeht Prognose

Tuesday, November 1st, 2011

Pfizer ( PFE ) Initial Recommendation Buy – Analyst rating from MKM Partners

Friday, October 7th, 2011

Fitch senkt Pfizer-Rating wegen langsamerem Schuldenabbau

Sunday, September 25th, 2011 « Previous Entries